BlackRock’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183M Buy
9,653,758
+291,837
+3% +$4.72M ﹤0.01% 1726
2025
Q4
$164M Buy
9,361,921
+1,998,128
+27% +$37.6M ﹤0.01% 1813
2025
Q3
$152M Buy
7,363,793
+517,126
+8% +$12.5M ﹤0.01% 1831
2025
Q2
$146M Sell
6,846,667
-1,550,889
-18% -$35.4M ﹤0.01% 1806
2025
Q1
$162M Sell
8,397,556
-33,968
-0.4% -$681K ﹤0.01% 1716
2024
Q4
$150M Buy
8,431,524
+336,839
+4% +$6.53M ﹤0.01% 1824
2024
Q3
$177M Buy
8,094,685
+196,100
+2% +$2.74M ﹤0.01% 1731
2024
Q2
$61.6M Sell
7,898,585
-1,924,756
-20% -$10.4M ﹤0.01% 2296
2024
Q1
$40.7M Buy
9,823,341
+63,958
+0.7% +$254K ﹤0.01% 2564
2023
Q4
$25.5M Buy
9,759,383
+782,464
+9% +$1.61M ﹤0.01% 2868
2023
Q3
$16.8M Buy
8,976,919
+214,078
+2% +$408K ﹤0.01% 3041
2023
Q2
$22M Buy
8,762,841
+6,917,788
+375% +$12.6M ﹤0.01% 2988
2023
Q1
$3.23M Buy
1,845,053
+1,310,393
+245% +$3.57M ﹤0.01% 3831
2022
Q4
$2.27M Buy
534,660
+113,574
+27% +$207K ﹤0.01% 4087
2022
Q3
$500K Buy
421,086
+118,878
+39% +$134K ﹤0.01% 4732
2022
Q2
$302K Sell
302,208
-1,062,985
-78% -$1.49M ﹤0.01% 4921
2022
Q1
$3.34M Sell
1,365,193
-35,547
-3% -$89.6K ﹤0.01% 4163
2021
Q4
$3.77M Buy
1,400,740
+200,150
+17% +$962K ﹤0.01% 4122
2021
Q3
$6.01M Buy
1,200,590
+105,443
+10% +$757K ﹤0.01% 3882
2021
Q2
$8.17M Buy
1,095,147
+348,045
+47% +$2.28M ﹤0.01% 3711
2021
Q1
$4.38M Buy
747,102
+16,492
+2% +$106K ﹤0.01% 4000
2020
Q4
$3.43M Buy
+730,610
New +$3.09M ﹤0.01% 3850

Other funds holding SMMT